iPSC ‐derived microglia carrying the TREM2 R47H /+ mutation are proinflammatory and promote synapse loss
Glia · 2024-02 · 72 (2) · 452-469
DOI: 10.1002/glia.24485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 15.11.2023. Verfasst von Jay Penney und 8 weiteren Autor:innen. Beteiligte Einrichtung: Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Alzheimer Disease. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Genetic findings have highlighted key roles for microglia in the pathology of neurodegenerative conditions such as Alzheimer's disease (AD). A number of mutations in the microglial protein triggering receptor expressed on myeloid cells 2 (TREM2) have been associated with increased risk for developing AD, most notably the R47H/+ substitution. We employed gene editing and stem cell models to gain insight into the effects of the TREM2 R47H/+ mutation on human‐induced pluripotent stem cell‐derived microglia. We found transcriptional changes affecting numerous cellular processes, with R47H/+ cells exhibiting a proinflammatory gene expression signature. TREM2 R47H/+ also caused impairments in microglial movement and the uptake of multiple substrates, as well as rendering microglia hyperresponsive to inflammatory stimuli. We developed an in vitro laser‐induced injury model in neuron–microglia cocultures, finding an impaired injury response by TREM2 R47H/+ microglia. Furthermore, mouse brains transplanted with TREM2 R47H/+ microglia exhibited reduced synaptic density, with upregulation of multiple complement cascade components in TREM2 R47H/+ microglia suggesting inappropriate synaptic pruning as one potential mechanism. These findings identify a number of potentially detrimental effects of the TREM2 R47H/+ mutation on microglial gene expression and function likely to underlie its association with AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Department of Biomedical Sciences, AVC, University of Prince Edward Island, Charlottetown, PE, Canada.
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
ORCID-Profile: Jay Penney
Förderung
- NIA NIH HHS
Zitieren
APA
Penney, J., Ralvenius, W. T., Loon, A., Cerit, O., Dileep, V., Milo, B., Pao, P. C., Woolf, H., & Tsai, L. H. (2024). iPSC ‐derived microglia carrying the TREM2 R47H /+ mutation are proinflammatory and promote synapse loss. Glia, 72(2), 452-469. https://doi.org/10.1002/glia.24485
Vancouver
Penney J, Ralvenius WT, Loon A, Cerit O, Dileep V, Milo B, et al. iPSC ‐derived microglia carrying the TREM2 R47H /+ mutation are proinflammatory and promote synapse loss. Glia. 2024;72(2):452-469. doi:10.1002/glia.24485
BibTeX
@article{Penney2024,
author = {Penney, Jay and Ralvenius, William T and Loon, Anjanet and Cerit, Oyku and Dileep, Vishnu and Milo, Blerta and Pao, Ping-Chieh and Woolf, Hannah and Tsai, Li-Huei},
title = {iPSC ‐derived microglia carrying the TREM2 R47H /+ mutation are proinflammatory and promote synapse loss},
journal = {Glia},
year = {2024},
volume = {72},
number = {2},
pages = {452--469},
doi = {10.1002/glia.24485}
}
EUVIMED